Beth McCormick to Anti-Bacterial Agents
This is a "connection" page, showing publications Beth McCormick has written about Anti-Bacterial Agents.
Connection Strength
0.292
-
Palmer JD, Mortzfeld BM, Piattelli E, Silby MW, McCormick BA, Bucci V. Microcin H47: A Class IIb Microcin with Potent Activity Against Multidrug Resistant Enterobacteriaceae. ACS Infect Dis. 2020 04 10; 6(4):672-679.
Score: 0.112
-
Daniel VT, Francalancia S, Amir NS, Ayturk MD, Sanders SB, Wisler JR, Collins CE, Ward DV, Kiefe CI, McCormick BA, Santry HP. Upper Gastrointestinal Perforations: A Possible Danger of Antibiotic Overuse. J Gastrointest Surg. 2020 12; 24(12):2730-2736.
Score: 0.110
-
Kellogg TD, Ceglia S, Mortzfeld BM, Tanna TM, Zeamer AL, Mancini MR, Foley SE, Ward DV, Bhattarai SK, McCormick BA, Reboldi A, Bucci V. Succinate-producing microbiota drives tuft cell hyperplasia to protect against Clostridioides difficile. J Exp Med. 2025 Jan 06; 222(1).
Score: 0.039
-
Mortzfeld BM, Palmer JD, Bhattarai SK, Dupre HL, Mercado-Lubio R, Silby MW, Bang C, McCormick BA, Bucci V. Microcin MccI47 selectively inhibits enteric bacteria and reduces carbapenem-resistant Klebsiella pneumoniae colonization in vivo when administered via an engineered live biotherapeutic. Gut Microbes. 2022 Jan-Dec; 14(1):2127633.
Score: 0.032